P1 - Plenary opening symposium: Smart therapeutics
If you are not registered yet, click HERE for more information how to register for PSWC2020
Chair
Denis DeBlois, Chair of the International Scientific Programme Commitee PSWCIntroduction
How can we best foster pharmaceutical science innovation and its translation into the clinic? The current COVID-19 pandemic is an opportunity for pharmaceutical scientists to reflect on the traditional models for drug discovery, development, access and clinical usage to make them more efficient, while maintaining the highest quality. Now more than ever, we need to step up to face global health challenges. This session will bring together a global audience and experts around the theme Smart therapeutics for a complex world.
Programme
Welcome address
Giovanni Pauletti, FIP Scientific Secretary, USA
Lyne Lalonde, dean of the Faculty of pharmacy, Université de Montréal
Challenges to therapeutic repurposing and development in a pandemic
Steven Kern, Bill and Melinda Gates Foundation, USA
How translational sciences are harnessed to face COVID-19
Joni Rutter, NCATS, USA
Ensuring the global supply of quality medicines: the response to COVID-19
Michael Levy, US Pharmacopeia, USA
The future of drug R&D
Bernard Munos, FasterCure /Milken Institute, USA